Harrow News

Harrow Q2 2024 Adj. EPS $(0.06) Beats $(0.20) Estimate, Sales $48.939M Beat $42.509M Estimate

BenzingaAug 7 16:40 ET

Harrow, Inc. (HROW) Q2 2024 Earnings Call Transcript

Earnings Call Transcripts21minutes ago

10 Health Care Stocks Whale Activity In Today's Session

Benzinga45minutes ago

Top Premarket Gainers

MT NewswiresAug 8 07:53 ET

10-Q: Q2 2024 Earnings Report

SEC announcementAug 7 17:17 ET · Announcements

Express News | Harrow Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results

BenzingaAug 7 16:42 ET

Express News | Harrow Inc Shares up 29.66% at $28.50 in Extended Trade Following Results

ReutersAug 7 16:18 ET

Earnings Flash (HROW) HARROW Posts Q2 Loss $-0.06, Vs. Street Est of $-0.11

MT NewswiresAug 7 16:07 ET

Express News | Harrow Announces Second Quarter 2024 Financial Results

ReutersAug 7 16:01 ET

Express News | Harrow Health Q2 Core EPS USD -0.06 Vs. IBES Estimate USD -0.2

ReutersAug 7 16:01 ET

Express News | Harrow Health Q2 EPS USD -0.18

ReutersAug 7 16:01 ET

Express News | Harrow Health Q2 Revenue USD 48.9 Million Vs. IBES Estimate USD 42.5 Million

ReutersAug 7 16:01 ET

Express News | Harrow Health Q2 Core Gross Margin 79%

ReutersAug 7 16:01 ET

Harrow 2Q Loss/Shr 18c >HROW

Dow JonesAug 7 16:01 ET

Here Is the Next Potential Market Catalyst

Seeking AlphaAug 7 10:00 ET

Harrow Health's Strong Market Performance and Growth Prospects Justify Buy Rating

TipRanksJul 31 12:15 ET · Ratings

Novaliq Receives Positive CHMP Opinion for Vevizye in Dry Eye Disease

BusinesswireJul 29 08:00 ET

Harrow Health's Growth Trajectory: A Strong Buy Rating With a $29 Price Target

TipRanksJul 26 08:15 ET · Ratings

Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024

BusinesswireJul 25 07:00 ET

Harrow Health (HROW) Gets a Buy From Craig-Hallum

TipRanksJul 15 08:56 ET